Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
SeraCare Life Sciences completed its implementation of SAP enterprise resource planning (ERP) software. The SAP system integrates the company’s inventory planning and control, purchasing, production management, quality management, and financial reporting systems into a single software solution.
Medica’s Competency Review software for its EasyCell assistant cell imaging system for hematology labs integrates evaluations of technologists into the laboratory’s daily routine. With the software, an instructor can train and evaluate the expertise of technologists in classifying white cells and red cell morphology.
Audit MicroControls received 510(k) clearance from the FDA, allowing the addition of assayed lithium to Audit’s therapeutic drug monitoring daily quality control and calibration verification/linearity kits. With the addition of lithium, Audit’s TDM linearity kit will have five levels and 14 assayed analytes and the control will have three levels and 13 assayed analytes.
Diagnostica Stago expanded its line of automated hemostasis analyzers with the launch of the STA Compact Max Hemostasis Testing System, a coagulation testing solution for mid- to high-volume laboratories. The new touchscreen user interface enables intuitive operation at any skill level, and the system’s integrated expert module offers autoverification, expert rules, an advanced QC system, and electronic lot conversion.
Beckman Coulter Life Sciences’ new reagent kits for intracellular staining minimize sample manipulation for a streamlined workflow. Developed for use on Beckman Coulter’s Gallios and Navios series flow cytometers and compatible with all Beckman fluorochromes, the kits enable a clear focus on the cytoplasmic and nuclear compartments of the cell.
Gold Standard Diagnostics announced FDA 510(k) clearance of its 25-OH vitamin D, total ELISA. This assay correlates with established liquid chromatography/mass spectrometry, enzyme immunoassay, and chemiluminescence methods, and offers high sensitivity and specificity over a wide dynamic range. The assay can be automated on a variety of instruments, providing a cost-effective vitamin D testing option even at lower volumes.
Seegene’s novel real-time array technology is designed to accelerate the development of point-of-care testing by eliminating steps that normally follow PCR amplification, and that are required for conventional arrays. The new technology unifies all the steps into one. There is no size limitation for the PCR amplicon, and the array technology requires no asymmetric PCR, denaturation of the PCR amplicon, target specific primer extension, signal amplification, or washing step.
Alere has received FDA approval to market its Alere Determine HIV-1/2 Ag/Ab Combo in the United States. The Alere Determine HIV-1/2 Ag/Ab Combo is a rapid point-of-care test that detects both HIV-1/2 antibodies and the HIV-1 p24 antigen, which can appear days after infection and prior to HIV-1/2 antibodies.
BD Diagnostics and Diagenode announced the European-only launch of the Diagenode Bordetella pertussis/parapertussis real-time PCR kit for use on the BD Max system. The kit has been CE-marked and validated to run on the BD Max system using the BD Max ExK DNA-1 extraction kit, an open-system reagent. BD Diagnostics, 800-675-0938 Diagenode, 862-209-4680
PolyScience’s performance programmable circulating baths make it simple to create and run multi-step ramp and soak temperature programs as well as frequently used single temperature testing protocols. The baths have an icon-driven touchscreen display that makes it easy to select and set operational parameters. A built-in electronic keypad speeds and simplifies the entry of text and numerical values. Available in refrigerating/heating and heat-only models, PolyScience performance programmable circulating baths control bath temperatures from −40°C to 200°C with ±0.005°C stability and
